Atorvastatin and Repatha represent two distinct approaches to managing cholesterol levels and reducing cardiovascular risk. As cardiovascular diseases continue to be a leading cause of mortality worldwide, the importance of effective cholesterol management cannot be overstated. Elevated levels of low-density lipoprotein (LDL) cholesterol are a significant risk factor for heart attacks and strokes, prompting the need for medications that can effectively lower these levels. Atorvastatin, a member of the statin family, has been widely used for years as a first-line treatment for high cholesterol. It works by inhibiting an enzyme involved in cholesterol production in the liver, thus reducing LDL cholesterol levels. On the other hand, Repatha, a monoclonal antibody,…